US PEPFAR abstinence and faithfulness funding had no impact on sexual behaviour in Africa
HIV maturation inhibitor BMS-955176 looks promising in early study
Starting HIV treatment at CD4 count above 500 reduces the risk of serious illness and death by 44%, African Temprano trial shows
Combining PrEP and ART could almost eliminate HIV infection, east African study finds
XDR-TB in South Africa is largely spread person-to-person, not by failure of drug treatment
Stopping cotrimoxazole during antiretroviral therapy raises risk of bacterial illness, malaria, Ugandan trial shows
Week-on, weekend-off treatment controls viral load in young people
PrEP use rising in San Francisco, but scaling up could further cut new infections
Disappointing result for tenofovir-gel microbicide shows that young women still lack HIV prevention methods they can use
